Prevalence of hepatitis B virus infection in Kenya: A study nested in the Kenya Population-based HIV Impact Assessment 2018
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0310923 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Raphael O Ondondo und 17 weiteren Autor:innen. Beteiligte Einrichtung: Division of Global HIV&TB, Center for Global Health, US Centers for Disease Control and Prevention (CDC), Nairobi, Kenya. Hauptthemen laut MEDLINE: HIV Infections, Hepatitis B. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: CGH CDC HHS, U.S. President’s Emergency Plan for AIDS Relief.
Abstract (Originalsprache)
Background
Sub-Saharan Africa region bears the highest chronic hepatitis B virus (HBV) infection burden worldwide. National estimates of HBV burden are necessary for a viral hepatitis program planning. This study estimated the national prevalence of HBV infection in Kenya among people aged 15–64 years.
Methods
Of 27,745 participants age 15–64 years in the Kenya Population-based HIV Impact Assessment (KENPHIA) 2018 household survey, we analyzed data for all persons living with HIV (PLHIV; n = 1,521) and a random sample of HIV-negative persons (n = 1,551), totaling to 3,072 participants. We tested whole blood samples for hepatitis B surface antigen (HBsAg) using Determine™ HBsAg rapid test and used population projections to estimate national disease burden. Pearson chi square was performed and the weighted prevalence proportions presented.
Findings
Of the 3,072 participants,124 tested HBsAg positive, resulting in a weighted national HBV prevalence of 3.0% (95% CI: 2.2–3.9%). This translated to an HBV infection burden of 810,600 (95% CI: 582,700–1,038,600) persons age 15–64 years in Kenya. Distribution of HBV prevalence varied widely (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Global HIV&TB, Center for Global Health, US Centers for Disease Control and Prevention (CDC), Nairobi, Kenya.
- National AIDS and STI Control Program (NASCOP), Ministry of Health, Nairobi, Kenya.
- Kenya Medical Research Institute (KEMRI), Nairobi, Kenya.
- Division of Global HIV&TB, Center for Global Health, US Centers for Disease Control and Prevention (CDC), Maputo, Mozambique.
- Center for Global Health, U.S. National Cancer Institute, Bethesda, Maryland, USA-based in Nairobi, Kenya.
- Division of Global HIV&TB, Center for Global Health, US Centers for Disease Control and Prevention (CDC), Atlanta, GA, United States of America.
ORCID-Profile: Raphael O Ondondo, Jacques Muthusi, Peter Young
Förderung
- CGH CDC HHS
- U.S. President’s Emergency Plan for AIDS Relief
Zitieren
APA
Ondondo, R. O., Muthusi, J., Oramisi, V., Kimani, D., Ochwoto, M., Young, P., Ngugi, C., Waruru, A., Mwangi, J., Chao, A., Bronson, M., Dobbs, T., Ng'ang'a, L., Bowen, N., Aoko, A., Armstrong, P. A., Aman, R., & Bulterys, M. (2024). Prevalence of hepatitis B virus infection in Kenya: A study nested in the Kenya Population-based HIV Impact Assessment 2018. PLOS ONE. https://doi.org/10.1371/journal.pone.0310923
Vancouver
Ondondo RO, Muthusi J, Oramisi V, Kimani D, Ochwoto M, Young P, et al. Prevalence of hepatitis B virus infection in Kenya: A study nested in the Kenya Population-based HIV Impact Assessment 2018. PLOS ONE. 2024. doi:10.1371/journal.pone.0310923
BibTeX
@article{Ondondo2024,
author = {Ondondo, Raphael O and Muthusi, Jacques and Oramisi, Violet and Kimani, Daniel and Ochwoto, Missiani and Young, Peter and Ngugi, Catherine and Waruru, Anthony and Mwangi, Jane and Chao, Ann and Bronson, Megan and Dobbs, Trudy and Ng'ang'a, Lucy and Bowen, Nancy and Aoko, Appolonia and Armstrong, Paige A and Aman, Rashid and Bulterys, Marc},
title = {Prevalence of hepatitis B virus infection in Kenya: A study nested in the Kenya Population-based HIV Impact Assessment 2018},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0310923}
}
EUVIMED